MHRA Class 2 Medicines Recall: Maxolon 5mg/ml (AMCo), solution for injection, 2ml ampoules

MHRA-for-website-300x115

MHRA Class 2 Medicines Recall: Maxolon 5mg/ml (AMCo), solution for injection, 2ml ampoules

March 1, 2016

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug alert for specific batches of:

Maxolon 5mg/ml (AMCo), solution for injection, 2ml ampoules, PL 20072/0051

This is due to the outer carton containing incorrect administration instructions . This is a pharmacy level recall and must be actioned within 48 hours.

To view the alert please visit the MHRA website.



Posted in:


More Latest News >

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and...

EPS nomination – core principles

This briefing provides pharmacy teams with information about the core principles of Electronic Prescription Service (EPS) Nomination. PSNC Briefing 034/16:...

July CPN is now online

The July edition of PSNC’s Community Pharmacy News is now available. This month’s CPN features: Pharmacy gains third party support...

Antibiotic Guardian roadshows 2016

Public Health England is running two events to disseminate information on antimicrobial stewardship and infection prevention and control. The events will be...